vital results for birtamimab in al amyloidosis
Published 4 years ago • 532 plays • Length 1:35Download video MP4
Download video MP3
Similar videos
-
1:36
results from vital: survival benefit of birtamimab in mayo stage iv al amyloidosis
-
1:23
affirm-al: birtamimab vs placebo in patients with mayo stage iv al amyloidosis
-
5:07
daratumumab in the management of al amyloidosis
-
2:56
early vs. deferred transplantation in al amyloidosis
-
1:45
role for mrd assessment in al amyloidosis?
-
5:16
the evolution of al amyloidosis therapy
-
4:04
management of al amyloidosis: measurement modalities, transplantation & car-t
-
1:51
thrombotic and bleeding complications in al amyloidosis
-
5:17
amyloidosis: the voice of the patient
-
8:27
cardiac amyloidosis - what is amyloid and how does it affect the heart?
-
4:33
organ involvement in al amyloidosis
-
1:03
real-world management of patients with al amyloidosis
-
1:45
real-world data in guiding amyloidosis treatment
-
5:39
new organ response criteria in amyloidosis diagnosis
-
1:53
novel laboratory-based therapeutic approach in al amyloidosis: investigating flc secretion
-
5:00
diagnosing and treating al amyloidosis: a 2020 update from dr morie gertz
-
0:52
tocilizumab for aa amyloidosis
-
2:33
frail populations in al amyloidosis
-
2:23
the use of solid organ transplant in al amyloidosis
-
2:09
considerations for the timing of transplantation in al amyloidosis
-
3:15
goal of therapy in al amyloidosis: what predicts the best outcome?
-
2:20
new prognostic markers in al amyloidosis